Pharmacoepidemiology and Drug Safety

Cover image for Pharmacoepidemiology and Drug Safety

April/May 2002

Volume 11, Issue 3

Pages 185–270

  1. Editorials

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Responses to Editorials
    5. Original Reports
    6. ISPE Commentaries
    7. Editorials
    8. Current Awareness
  2. Original Reports

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Responses to Editorials
    5. Original Reports
    6. ISPE Commentaries
    7. Editorials
    8. Current Awareness
  3. Responses to Editorials

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Responses to Editorials
    5. Original Reports
    6. ISPE Commentaries
    7. Editorials
    8. Current Awareness
    1. Response to Editorial by Dr Neal Halsey (pages 203–204)

      John L. Sever, Alan I. Brenner, Arnold D. Gale, Jerry M. Lyle, Lawrence H. Moulton and David J. West

      Version of Record online: 3 MAY 2002 | DOI: 10.1002/pds.716

  4. Original Reports

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Responses to Editorials
    5. Original Reports
    6. ISPE Commentaries
    7. Editorials
    8. Current Awareness
    1. Contribution of pharmacists to the reporting of adverse drug reactions (pages 205–210)

      A. C. van Grootheest, E. P. van Puijenbroek and L. T. W. de Jong–van den Berg

      Version of Record online: 5 APR 2002 | DOI: 10.1002/pds.702

    2. Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease (pages 211–218)

      James D. Lewis, Colleen Brensinger, Warren B. Bilker and Brian L. Strom

      Version of Record online: 5 APR 2002 | DOI: 10.1002/pds.698

    3. Inpatient treatment of depression and associated hospital charges (pages 219–227)

      Deborah L. Ackerman, Jürgen Unützer, Sander Greenland and Michael Gitlin

      Version of Record online: 20 MAR 2002 | DOI: 10.1002/pds.694

    4. Hyponatremia and syndrome of inappropriate anti-diuretic hormone reported with the use of Vincristine®: an over-representation of Asians? (pages 229–234)

      Isaac W. Hammond, Jeffrey A. Ferguson, Kenneth Kwong, Edmundo Muniz and Frank Delisle

      Version of Record online: 5 APR 2002 | DOI: 10.1002/pds.695

    5. Adverse drug events in hospitalized patients treated with cardiovascular drugs and anticoagulants (pages 235–238)

      R. Zaidenstein, S. Eyal, S. Efrati, L. Akivison, M. Koren Michowitz, V. Nagornov and A. Golik

      Version of Record online: 3 MAY 2002 | DOI: 10.1002/pds.693

    6. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis (pages 239–245)

      M. Bäckström, S. Hägg, T. Mjörndal and R. Dahlqvist

      Version of Record online: 3 MAY 2002 | DOI: 10.1002/pds.697

  5. ISPE Commentaries

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Responses to Editorials
    5. Original Reports
    6. ISPE Commentaries
    7. Editorials
    8. Current Awareness
    1. Is there a need for critical ethical and philosophical evaluation of hospital drugs and therapeutics (D&T) committees? (pages 247–252)

      Roel Fijn, L. Sara van Epenhuysen, A. Jeanne M. Peijnenburg, Jacobus R. B. J. Brouwers and Lolkje T. W. de Jong-van den Berg

      Version of Record online: 3 MAY 2002 | DOI: 10.1002/pds.719

  6. Editorials

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Responses to Editorials
    5. Original Reports
    6. ISPE Commentaries
    7. Editorials
    8. Current Awareness
  7. Current Awareness

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Responses to Editorials
    5. Original Reports
    6. ISPE Commentaries
    7. Editorials
    8. Current Awareness

SEARCH

SEARCH BY CITATION